Jacobs Levy Equity Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17,753
| Closed | -$128K | – | 1060 |
|
|
2022
Q3 | $128K | Buy |
+17,753
| New | +$128K | ﹤0.01% | 954 |
|
|
2022
Q2 | – | Sell |
-138,279
| Closed | -$1.24M | – | 1113 |
|
|
2022
Q1 | $1.24M | Buy |
+138,279
| New | +$1.24M | 0.01% | 724 |
|
|
2019
Q3 | – | Sell |
-21,274
| Closed | -$90K | – | 1015 |
|
|
2019
Q2 | $90K | Buy |
+21,274
| New | +$90K | ﹤0.01% | 922 |
|
|
2017
Q3 | – | Sell |
-14,606
| Closed | -$141K | – | 1029 |
|
|
2017
Q2 | $141K | Sell |
14,606
-3,570
| -20% | -$34.5K | ﹤0.01% | 876 |
|
|
2017
Q1 | $212K | Buy |
18,176
+10,600
| +140% | +$124K | ﹤0.01% | 784 |
|
|
2016
Q4 | $68K | Buy |
+7,576
| New | +$68K | ﹤0.01% | 927 |
|
|
2016
Q2 | – | Sell |
-5,026
| Closed | -$84K | – | 1245 |
|
|
2016
Q1 | $84K | Buy |
+5,026
| New | +$84K | ﹤0.01% | 1048 |
|